Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry
Discussion These new compounds with novel mechanisms of action are
expected to provide a greater variety of treatment options for depression if
preliminary positive results are confirmed. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | open access Full text
Source: Pharmacopsychiatry - Category: Psychiatry Authors: Sakurai, Hitoshi Yonezawa, Kengo Tani, Hideaki Mimura, Masaru Bauer, Michael Uchida, Hiroyuki Tags: Review Source Type: research